This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Genetic engineering stocks tighten market amid weak offerings
The squeeze on biotech startups deepens as Molecular Genetics sold 450000 shares at $9, short of its $11-13 target, raising $4.05 million versus $11-13 million expected. Other firms report poor issues. analysts blame investors and early-stage tech hurdles, noting Genentech and others struggle despite past highs. Molecular Genetics pursues livestock vaccines and antitoxins.
MENTIONED IN THIS ARTICLE
Daniel Rosenheim
Chicago Sun-Times
Molecular Genetics
Franklin Pass
Collaborative Research
Southern Biotech